Assessment of intact fibroblast growth factor 23 in patients with heart failure with reduced ejection fraction

被引：0
作者：
Gruson, D. Damien [1 ]
Ahn, S. [1 ]
Ferracin, B. [1 ]
Rousseau, M. [1 ]
机构：
[1] St Luc Univ Clin, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1170
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [21] Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
    Anne Cornelissen
    Roberta Florescu
    Kinan Kneizeh
    Christian Cornelissen
    Vincent Brandenburg
    Elisa Liehn
    Alexander Schuh
    Scientific Reports, 11
  • [22] Fibroblast growth factor 23 in patients with heart failure: measurement of the intact form with a novel automated assay
    Gruson, Damien
    Ferracin, Benjamin
    Ahn, Sylvie
    Rousseau, Michel
    ACTA CARDIOLOGICA, 2017, 72 (01) : 93 - 94
  • [23] Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
    Liu, Dan
    Hu, Kai
    Schregelmann, Lena
    Hammel, Clara
    Lengenfelder, Bjorn Daniel
    Ertl, Georg
    Frantz, Stefan
    Nordbeck, Peter
    ESC HEART FAILURE, 2023, 10 (02): : 1358 - 1371
  • [24] Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction
    Roy, C.
    Slimani, A.
    De Meester, C.
    Amzulescu, M.
    Ferracin, B.
    Ginion, A.
    Pasquet, A.
    Vancraeynest, D.
    Vanoverschelde, J. -L.
    Gerber, B.
    Beauloye, C.
    Horman, S.
    Gruson, D.
    Pouleur, A. -C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 224 - 224
  • [25] Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
    Chou, Ruey-Hsing
    Huang, Po-Hsun
    Hsu, Chien-Yi
    Chang, Chun-Chin
    Leu, Hsin-Bang
    Huang, Chin-Chou
    Chen, Jaw-Wen
    Lin, Shing-Jong
    SCIENTIFIC REPORTS, 2016, 6
  • [26] Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
    Ruey-Hsing Chou
    Po-Hsun Huang
    Chien-Yi Hsu
    Chun-Chin Chang
    Hsin-Bang Leu
    Chin-Chou Huang
    Jaw-Wen Chen
    Shing-Jong Lin
    Scientific Reports, 6
  • [27] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [28] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    Armstrong, Paul W.
    Pieske, Burkert
    Anstrom, Kevin J.
    Ezekowitz, Justin
    Hernandez, Adrian F.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jia, Gang
    McNulty, Steven E.
    Patel, Mahesh J.
    Roessig, Lothar
    Koglin, Joerg
    O'Connor, Christopher M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) : 1883 - 1893
  • [29] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) : 1995 - 2008
  • [30] Hypertension in Patients with Heart Failure with Reduced Ejection Fraction
    Massimo Volpe
    Caterina Santolamazza
    Giuliano Tocci
    Current Cardiology Reports, 2016, 18
12345